Tramadol and Infusion site infection - a phase IV clinical study of FDA data

Summary:

Infusion site infection is reported as a side effect among people who take Tramadol (tramadol hydrochloride), especially for people who are female, 60+ old, also take Remodulin, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Infusion site infection when taking Tramadol. It is created by eHealthMe based on reports of 229,782 people who have side effects when taking Tramadol from the FDA, and is updated regularly.

What is Tramadol?

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,798 Tramadol users. Check the latest studies of Tramadol.

What is Infusion site infection?

Infusion site infection is found to be associated with 189 drugs and 173 conditions by eHealthMe. Check the latest studies of Infusion site infection.

On Jul, 15, 2026

229,782 people reported to have side effects when taking Tramadol.
Among them, 36 people (0.02%) have Infusion site infection.

Could Tramadol cause Infusion site infection?

Among these 36 people:

What is the gender of people who have Infusion site infection when taking Tramadol? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Infusion site infection when taking Tramadol? *

What are other drugs people take besides Tramadol? *

What are other side effects people have besides Infusion site infection? *

Pain In Extremity: 16 people, 44.44%
Nausea (feeling of having an urge to vomit): 15 people, 41.67%
Infusion Site Pain: 14 people, 38.89%
Headache (pain in head): 14 people, 38.89%
Fall: 10 people, 27.78%
Diarrhea: 10 people, 27.78%
Fever: 9 people, 25.00%
Fatigue (feeling of tiredness): 9 people, 25.00%
Joint Pain: 8 people, 22.22%
Infusion Site Reaction: 8 people, 22.22%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 22 people, 61.11%
Infusion Site Pain: 6 people, 16.67%
Immunodeficiency Common Variable: 5 people, 13.89%
Panic Disorder: 3 people, 8.33%
Hereditary Angioedema (recurrent episodes of severe swelling): 3 people, 8.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.78%
Sleep Disorder: 1 person, 2.78%
Migraine (headache): 1 person, 2.78%
Joint Pain: 1 person, 2.78%
Infusion Site Pruritus (severe itching at infusion site): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Tramadol and have Infusion site infection?

- Check whether Infusion site infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tramadol:

Tramadol (235,798 reports)

Browse all side effects of Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site infection:

Infusion site infection (189 drugs)

Browse all the conditions that are associated with Infusion site infection:

Infusion site infection (173 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.